Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 11
2022 9
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification.
Ferro M, Rocco B, Maggi M, Lucarelli G, Falagario UG, Del Giudice F, Crocetto F, Barone B, La Civita E, Lasorsa F, Brescia A, Catellani M, Busetto GM, Tataru OS, Terracciano D. Ferro M, et al. Among authors: la civita e. Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1061-1070. doi: 10.1080/14737159.2023.2277366. Epub 2023 Dec 15. Expert Rev Mol Diagn. 2023. PMID: 37897252 Review.
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.
La Civita E, Zannella C, Brusa S, Romano P, Schettino E, Salemi F, Carrano R, Gentile L, Punziano A, Lagnese G, Spadaro G, Franci G, Galdiero M, Terracciano D, Portella G, Loffredo S. La Civita E, et al. Viruses. 2023 Jul 30;15(8):1659. doi: 10.3390/v15081659. Viruses. 2023. PMID: 37632002 Free PMC article.
Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer.
La Civita E, Carbone G, Sicignano E, Crocetto F, Terracciano D. La Civita E, et al. J Basic Clin Physiol Pharmacol. 2023 Mar 27;34(3):245-247. doi: 10.1515/jbcpp-2023-0059. eCollection 2023 May 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 36972321 No abstract available.
A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer.
Gentile F, La Civita E, Ventura BD, Ferro M, Bruzzese D, Crocetto F, Tennstedt P, Steuber T, Velotta R, Terracciano D. Gentile F, et al. Among authors: la civita e. Cancers (Basel). 2023 Feb 21;15(5):1355. doi: 10.3390/cancers15051355. Cancers (Basel). 2023. PMID: 36900150 Free PMC article.
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG.
Contieri R, Hurle R, Paciotti M, Casale P, Saita A, Porpiglia F, Fiori C, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, Maggi M, Cantiello F, Damiano R, Borghesi M, Bove P, Bertolo R, Papalia R, Mari A, Luzzago S, Mistretta FA, Soria F, Gontero P, Marchioni M, LA Civita E, Terracciano D, Russo GI, Schips L, Perdona S, Mirone V, Tataru OS, Musi G, Vartolomei MD, Autorino R, Montanari E, DE Cobelli O, Ferro M. Contieri R, et al. Among authors: la civita e. Minerva Urol Nephrol. 2023 Apr;75(2):180-187. doi: 10.23736/S2724-6051.22.04953-9. Epub 2022 Oct 5. Minerva Urol Nephrol. 2023. PMID: 36197700 Free article.
31 results